PNC Financial Services Group’s NanoViricides NNVC Stock Holding History

PNC Financial Services Group’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-608	Closed	-$20K	–	4180
2016 Q2	$20K	Buy	+608	New	+$22.2K	﹤0.01%	3263

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return

PTB

Pioneer Trust Bank Salem, Oregon $441M AUM 21.13% 1-Year Est. Return

PNC Financial Services Group's NNVC Position: Q3 2016 in Review

PNC Financial Services Group sold out of NanoViricides (NNVC) in Q3 2016, closing a stake of 608 shares — an estimated $20K sold.

PNC Financial Services Group first reported a position in NNVC in Q2 2016 and held it in 1 quarter. The position peaked at $20K in Q2 2016. 41 funds tracked by Wall St. Rank hold NNVC as of Q3 2016.

PNC Financial Services Group reported no remaining NanoViricides position as of Q3 2016 after selling out during the quarter.
PNC Financial Services Group sold 608 NanoViricides shares in Q3 2016, an estimated $20K.
PNC Financial Services Group first reported a position in NanoViricides in Q2 2016 and held it in 1 quarter.
PNC Financial Services Group's NanoViricides position peaked at $20K in Q2 2016.
41 funds tracked by Wall St. Rank held NanoViricides as of Q3 2016.

Based on PNC Financial Services Group's 13F filing for Q3 2016, filed 4 Nov 2016.